Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common / Ordinary Stock
-
Total 13F shares
-
4,612,590
-
Share change
-
-150,694
-
Total reported value
-
$293,536,765
-
Price per share
-
$63.63
-
Number of holders
-
69
-
Value change
-
-$10,084,462
-
Number of buys
-
30
-
Number of sells
-
28
Institutional Holders of Taro Pharmaceutical Industries Ltd - Common / Ordinary Stock (TARO) as of Q3 2021
As of 30 Sep 2021,
Taro Pharmaceutical Industries Ltd - Common / Ordinary Stock (TARO) was held by
69 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,612,590 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, Krensavage Asset Management, LLC, DIMENSIONAL FUND ADVISORS LP, FMR LLC, ACADIAN ASSET MANAGEMENT LLC, BRANDES INVESTMENT PARTNERS, LP, Invesco Ltd., AMERIPRISE FINANCIAL INC, Eversept Partners, LP, and BlackRock Inc..
This page lists
69
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.